Quantification of Tamsulosin Hydrochloride and Solifenacin Succinate by Discriminative Derivative Synchronous Emission Spectroscopy
The present study was undertaken with the objective to develop and validate a simple spectrofluorimetric method for the simultaneous quantification of tamsulosin hydrochloride and solifenacin succinate. First-derivative synchronous spectrofluorimetry was attempted for the simultaneous quantification...
Gespeichert in:
| Veröffentlicht in: | The Turkish Journal of Pharmaceutical Sciences 2018-08, Vol.15 (2), p.149-155 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 155 |
|---|---|
| container_issue | 2 |
| container_start_page | 149 |
| container_title | The Turkish Journal of Pharmaceutical Sciences |
| container_volume | 15 |
| creator | Naraparaju, Swathi Anumolu, Pani Kumar D Gurrala, Sunitha Galennagari, Rajeshwari |
| description | The present study was undertaken with the objective to develop and validate a simple spectrofluorimetric method for the simultaneous quantification of tamsulosin hydrochloride and solifenacin succinate.
First-derivative synchronous spectrofluorimetry was attempted for the simultaneous quantification of the analytes. Tamsulosin hydrochloride was quantified at a wavelength of 322 nm (zero-crossing wavelength point of solifenacin succinate) and solifenacin succinate was measured at 570 nm (zero-crossing wavelength point of tamsulosin hydrochloride).
Calibration plots were constructed over the concentration range of 2-10 µg/mL for tamsulosin hydrochloride and 30-150 µg/mL for solifenacin succinate. The method gave satisfactory results when it is validated for linearity, specificity, accuracy, precision, LOD and LOQ as per the ICH guidelines. The assay values in the commercial formulation were found to be in the percentage range of 95.0 for tamsulosin hydrochloride and 103.5 for solifenacin succinate by the proposed method. These results were well in agreement with their label claim.
The proposed synchronous analytical method can be employed for routine quality control analysis of tamsulosin hydrochloride/solifenacin succinate in tablet dose forms. |
| doi_str_mv | 10.4274/tjps.72692 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7228008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2407313510</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-b017e66341a5d44157c5abc24eb6c3612eaf8f2cc7fb82aa7dc48a526ef866ef3</originalsourceid><addsrcrecordid>eNpdkk1rGzEQhkVpaUyaS39AWeihobCpvlZSLoUQu0nAEIpT6E1otVItI0tbadew5_7xynE-ml40EvPwzryjAeA9gmcUc_pl2PT5jGN2jl-BGUZU1AxT_hrMEIG0bgj8eQROct5ACNE5IVzQt-CIYNpQ1tAZ-PN9VGFw1mk1uBiqaKs7tc2jj9mF6nrqUtRrH5PrTKVCV62id9YEpUt2NeoS1GCqdqrmLuvktvu325lqbpLbHa6rKeh1iiGOuVpsXc77Oqve6CHFrGM_vQNvrPLZnDzEY_Dj2-Lu8rpe3l7dXF4sa02JGOoWIm4YIxSppqMUNVw3qtWYmpZpwhA2ygqLtea2FVgp3mkqVIOZsYKVgxyDrwfdfmy3ptMmDEl52Ze2VZpkVE6-zAS3lr_iTnKMBYSiCJw-CKT4ezR5kMWONt6rYIo7iSnkBJEGwYJ-_A_dxDGFYk_i8j-iCCJcqE8HqoxX-Ri8C-YZvJkvLpaSl-qokJ8PpC5Dy8nYp7YRlPtFkPtFkPeLUOAP_xp9Qh-_nfwF3qSzGA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2247828012</pqid></control><display><type>article</type><title>Quantification of Tamsulosin Hydrochloride and Solifenacin Succinate by Discriminative Derivative Synchronous Emission Spectroscopy</title><source>PMC (PubMed Central)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Naraparaju, Swathi ; Anumolu, Pani Kumar D ; Gurrala, Sunitha ; Galennagari, Rajeshwari</creator><contributor>Onur,Feyyaz</contributor><creatorcontrib>Naraparaju, Swathi ; Anumolu, Pani Kumar D ; Gurrala, Sunitha ; Galennagari, Rajeshwari ; Onur,Feyyaz</creatorcontrib><description>The present study was undertaken with the objective to develop and validate a simple spectrofluorimetric method for the simultaneous quantification of tamsulosin hydrochloride and solifenacin succinate.
First-derivative synchronous spectrofluorimetry was attempted for the simultaneous quantification of the analytes. Tamsulosin hydrochloride was quantified at a wavelength of 322 nm (zero-crossing wavelength point of solifenacin succinate) and solifenacin succinate was measured at 570 nm (zero-crossing wavelength point of tamsulosin hydrochloride).
Calibration plots were constructed over the concentration range of 2-10 µg/mL for tamsulosin hydrochloride and 30-150 µg/mL for solifenacin succinate. The method gave satisfactory results when it is validated for linearity, specificity, accuracy, precision, LOD and LOQ as per the ICH guidelines. The assay values in the commercial formulation were found to be in the percentage range of 95.0 for tamsulosin hydrochloride and 103.5 for solifenacin succinate by the proposed method. These results were well in agreement with their label claim.
The proposed synchronous analytical method can be employed for routine quality control analysis of tamsulosin hydrochloride/solifenacin succinate in tablet dose forms.</description><identifier>ISSN: 1304-530X</identifier><identifier>EISSN: 2148-6247</identifier><identifier>DOI: 10.4274/tjps.72692</identifier><identifier>PMID: 32454654</identifier><language>eng</language><publisher>Turkey: Türk Eczacılar Birliği</publisher><subject>Drug dosages ; Eczacılık ; International conferences ; Methods ; Original ; Pharmaceuticals ; Sağlık Hizmetleri ; Tıp ; Trends</subject><ispartof>The Turkish Journal of Pharmaceutical Sciences, 2018-08, Vol.15 (2), p.149-155</ispartof><rights>Copyright 2018 Turk J Pharm Sci, Published by Galenos Publishing House.</rights><rights>2018. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright 2018 Turk J Pharm Sci, Published by Galenos Publishing House. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-b017e66341a5d44157c5abc24eb6c3612eaf8f2cc7fb82aa7dc48a526ef866ef3</citedby><orcidid>0000-0003-1442-6435</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228008/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228008/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32454654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Onur,Feyyaz</contributor><creatorcontrib>Naraparaju, Swathi</creatorcontrib><creatorcontrib>Anumolu, Pani Kumar D</creatorcontrib><creatorcontrib>Gurrala, Sunitha</creatorcontrib><creatorcontrib>Galennagari, Rajeshwari</creatorcontrib><title>Quantification of Tamsulosin Hydrochloride and Solifenacin Succinate by Discriminative Derivative Synchronous Emission Spectroscopy</title><title>The Turkish Journal of Pharmaceutical Sciences</title><addtitle>Turk J Pharm Sci</addtitle><description>The present study was undertaken with the objective to develop and validate a simple spectrofluorimetric method for the simultaneous quantification of tamsulosin hydrochloride and solifenacin succinate.
First-derivative synchronous spectrofluorimetry was attempted for the simultaneous quantification of the analytes. Tamsulosin hydrochloride was quantified at a wavelength of 322 nm (zero-crossing wavelength point of solifenacin succinate) and solifenacin succinate was measured at 570 nm (zero-crossing wavelength point of tamsulosin hydrochloride).
Calibration plots were constructed over the concentration range of 2-10 µg/mL for tamsulosin hydrochloride and 30-150 µg/mL for solifenacin succinate. The method gave satisfactory results when it is validated for linearity, specificity, accuracy, precision, LOD and LOQ as per the ICH guidelines. The assay values in the commercial formulation were found to be in the percentage range of 95.0 for tamsulosin hydrochloride and 103.5 for solifenacin succinate by the proposed method. These results were well in agreement with their label claim.
The proposed synchronous analytical method can be employed for routine quality control analysis of tamsulosin hydrochloride/solifenacin succinate in tablet dose forms.</description><subject>Drug dosages</subject><subject>Eczacılık</subject><subject>International conferences</subject><subject>Methods</subject><subject>Original</subject><subject>Pharmaceuticals</subject><subject>Sağlık Hizmetleri</subject><subject>Tıp</subject><subject>Trends</subject><issn>1304-530X</issn><issn>2148-6247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkk1rGzEQhkVpaUyaS39AWeihobCpvlZSLoUQu0nAEIpT6E1otVItI0tbadew5_7xynE-ml40EvPwzryjAeA9gmcUc_pl2PT5jGN2jl-BGUZU1AxT_hrMEIG0bgj8eQROct5ACNE5IVzQt-CIYNpQ1tAZ-PN9VGFw1mk1uBiqaKs7tc2jj9mF6nrqUtRrH5PrTKVCV62id9YEpUt2NeoS1GCqdqrmLuvktvu325lqbpLbHa6rKeh1iiGOuVpsXc77Oqve6CHFrGM_vQNvrPLZnDzEY_Dj2-Lu8rpe3l7dXF4sa02JGOoWIm4YIxSppqMUNVw3qtWYmpZpwhA2ygqLtea2FVgp3mkqVIOZsYKVgxyDrwfdfmy3ptMmDEl52Ze2VZpkVE6-zAS3lr_iTnKMBYSiCJw-CKT4ezR5kMWONt6rYIo7iSnkBJEGwYJ-_A_dxDGFYk_i8j-iCCJcqE8HqoxX-Ri8C-YZvJkvLpaSl-qokJ8PpC5Dy8nYp7YRlPtFkPtFkPeLUOAP_xp9Qh-_nfwF3qSzGA</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>Naraparaju, Swathi</creator><creator>Anumolu, Pani Kumar D</creator><creator>Gurrala, Sunitha</creator><creator>Galennagari, Rajeshwari</creator><general>Türk Eczacılar Birliği</general><general>Galenos Publishing House</general><general>Galenos Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IEBAR</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1442-6435</orcidid></search><sort><creationdate>20180801</creationdate><title>Quantification of Tamsulosin Hydrochloride and Solifenacin Succinate by Discriminative Derivative Synchronous Emission Spectroscopy</title><author>Naraparaju, Swathi ; Anumolu, Pani Kumar D ; Gurrala, Sunitha ; Galennagari, Rajeshwari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-b017e66341a5d44157c5abc24eb6c3612eaf8f2cc7fb82aa7dc48a526ef866ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Drug dosages</topic><topic>Eczacılık</topic><topic>International conferences</topic><topic>Methods</topic><topic>Original</topic><topic>Pharmaceuticals</topic><topic>Sağlık Hizmetleri</topic><topic>Tıp</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Naraparaju, Swathi</creatorcontrib><creatorcontrib>Anumolu, Pani Kumar D</creatorcontrib><creatorcontrib>Gurrala, Sunitha</creatorcontrib><creatorcontrib>Galennagari, Rajeshwari</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Idealonline online kütüphane - Journals</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Turkish Journal of Pharmaceutical Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Naraparaju, Swathi</au><au>Anumolu, Pani Kumar D</au><au>Gurrala, Sunitha</au><au>Galennagari, Rajeshwari</au><au>Onur,Feyyaz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantification of Tamsulosin Hydrochloride and Solifenacin Succinate by Discriminative Derivative Synchronous Emission Spectroscopy</atitle><jtitle>The Turkish Journal of Pharmaceutical Sciences</jtitle><addtitle>Turk J Pharm Sci</addtitle><date>2018-08-01</date><risdate>2018</risdate><volume>15</volume><issue>2</issue><spage>149</spage><epage>155</epage><pages>149-155</pages><issn>1304-530X</issn><eissn>2148-6247</eissn><abstract>The present study was undertaken with the objective to develop and validate a simple spectrofluorimetric method for the simultaneous quantification of tamsulosin hydrochloride and solifenacin succinate.
First-derivative synchronous spectrofluorimetry was attempted for the simultaneous quantification of the analytes. Tamsulosin hydrochloride was quantified at a wavelength of 322 nm (zero-crossing wavelength point of solifenacin succinate) and solifenacin succinate was measured at 570 nm (zero-crossing wavelength point of tamsulosin hydrochloride).
Calibration plots were constructed over the concentration range of 2-10 µg/mL for tamsulosin hydrochloride and 30-150 µg/mL for solifenacin succinate. The method gave satisfactory results when it is validated for linearity, specificity, accuracy, precision, LOD and LOQ as per the ICH guidelines. The assay values in the commercial formulation were found to be in the percentage range of 95.0 for tamsulosin hydrochloride and 103.5 for solifenacin succinate by the proposed method. These results were well in agreement with their label claim.
The proposed synchronous analytical method can be employed for routine quality control analysis of tamsulosin hydrochloride/solifenacin succinate in tablet dose forms.</abstract><cop>Turkey</cop><pub>Türk Eczacılar Birliği</pub><pmid>32454654</pmid><doi>10.4274/tjps.72692</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-1442-6435</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1304-530X |
| ispartof | The Turkish Journal of Pharmaceutical Sciences, 2018-08, Vol.15 (2), p.149-155 |
| issn | 1304-530X 2148-6247 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7228008 |
| source | PMC (PubMed Central); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Drug dosages Eczacılık International conferences Methods Original Pharmaceuticals Sağlık Hizmetleri Tıp Trends |
| title | Quantification of Tamsulosin Hydrochloride and Solifenacin Succinate by Discriminative Derivative Synchronous Emission Spectroscopy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T07%3A26%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantification%20of%20Tamsulosin%20Hydrochloride%20and%20Solifenacin%20Succinate%20by%20Discriminative%20Derivative%20Synchronous%20Emission%20Spectroscopy&rft.jtitle=The%20Turkish%20Journal%20of%20Pharmaceutical%20Sciences&rft.au=Naraparaju,%20Swathi&rft.date=2018-08-01&rft.volume=15&rft.issue=2&rft.spage=149&rft.epage=155&rft.pages=149-155&rft.issn=1304-530X&rft.eissn=2148-6247&rft_id=info:doi/10.4274/tjps.72692&rft_dat=%3Cproquest_pubme%3E2407313510%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2247828012&rft_id=info:pmid/32454654&rfr_iscdi=true |